Vedolizumab in IBD/PSC: A Case for Careful Vigilance?

J Crohns Colitis. 2019 Sep 27;13(10):1237-1238. doi: 10.1093/ecco-jcc/jjz102.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Cholangitis, Sclerosing*
  • Cohort Studies
  • Humans
  • Inflammatory Bowel Diseases*

Substances

  • Antibodies, Monoclonal, Humanized
  • vedolizumab